---
title: "Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi"
description: "Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/273785942.md"
published_at: "2026-01-27T04:12:44.000Z"
---

# Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi

### Related Stocks

- [512290.CN - Guotai CSI Bio-medicine ETF](https://longbridge.com/en/quote/512290.CN.md)
- [513060.CN - Bosera Hang Seng Health Care ETF(QDII)](https://longbridge.com/en/quote/513060.CN.md)
- [159992.CN - Yinhua CSI Innovative Drugs Industry ETF](https://longbridge.com/en/quote/159992.CN.md)
- [510660.CN - ChinaAMC SSE Health Care ETF Initiating Fund](https://longbridge.com/en/quote/510660.CN.md)
- [520690.CN - Bosera Hang Seng SCHK Innovative Drug Select ETF](https://longbridge.com/en/quote/520690.CN.md)
- [159837.CN - E Fund CSI Biotechnology Theme ETF](https://longbridge.com/en/quote/159837.CN.md)
- [513120.CN - GF CSI HK Innovative Drugs Industry ETF(QDII)](https://longbridge.com/en/quote/513120.CN.md)
- [159316.CN - E Fund Hang Seng SCHK Innovative Drug ETF](https://longbridge.com/en/quote/159316.CN.md)
- [02228.HK - XTALPI](https://longbridge.com/en/quote/02228.HK.md)
- [588130.CN - ChinaAMC SSE STAR Biology and Medicine ETF](https://longbridge.com/en/quote/588130.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| Abbisko Cayman Board to Approve Audited Annual Results and Consider Final Dividend | Abbisko Cayman Ltd. will hold a board meeting on March 2, 2026, to approve its audited annual results for the year endin | [Link](https://longbridge.com/en/news/275573355.md) |
| Beijing Tong Ren Tang Chinese Medicine Co. Ltd. Held Extraordinary General Meeting | Beijing Tong Ren Tang Chinese Medicine Co. Ltd. held an extraordinary general meeting on February 11, 2026, where all pr | [Link](https://longbridge.com/en/news/275583242.md) |
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/en/news/276024005.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
